Genetically engineered T cells to target EGFRvIII expressing glioblastoma.
Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter BS.
Bullain SS, et al.
J Neurooncol. 2009 Sep;94(3):373-82. doi: 10.1007/s11060-009-9889-1. Epub 2009 Apr 23.
J Neurooncol. 2009.
PMID: 19387557
Free PMC article.